Eurofins Pharma Bioanalytical Services announces new consulting services

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/jakkaje808)
(Image: iStock/jakkaje808)

Related tags: Contract research organization

Eurofins Pharma Bioanalytical Services has launched a consulting program to support clients conducting large molecule preclinical and clinical studies.

The large molecule-focused bioanalytical and biomarker contract research organization (CRO) has facilities in Oxford, UK and St. Charles, US.

The company develops, transfers, and validates large molecule PK, ADA and biomarker assays and offers various pre-qualified assays.

According to the company​, the Eurofins Pharma Bioanalytical Services consulting program will provide guidance on bioanalytical assay development and assay validation.

Eurofins Bioanalytical Services did not respond to a request for comment.

Related news

Show more

Related products

show more

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Local lab Data Management

Local lab Data Management

Q2 Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q2 Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Related suppliers

Follow us

Products

View more

Webinars